BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9240728)

  • 1. Optimizing Thyroxine Dosage After Total Thyroidectomy: Understanding the Factors at Play.
    Dawn Paul E; T V S; Sulaiman SV
    Cureus; 2024 Apr; 16(4):e58430. PubMed ID: 38765445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma.
    Zanella AB; Marmitt L; Fighera TM; Scheffel RS; Spritzer PM; Dora JM; Maia AL
    Metabolites; 2022 Sep; 12(9):. PubMed ID: 36144246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH suppressive therapy and bone.
    Brancatella A; Marcocci C
    Endocr Connect; 2020 Jul; 9(7):R158-R172. PubMed ID: 32567550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case-Control Study in U.S. Veterans.
    Papaleontiou M; Banerjee M; Reyes-Gastelum D; Hawley ST; Haymart MR
    Oncologist; 2019 Sep; 24(9):1166-1173. PubMed ID: 31164453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.
    Papaleontiou M; Hawley ST; Haymart MR
    Oncologist; 2016 Feb; 21(2):165-71. PubMed ID: 26659220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism.
    Karimifar M; Esmaili F; Salari A; Kachuei A; Faragzadegan Z; Karimifar M
    J Res Pharm Pract; 2014 Jul; 3(3):83-7. PubMed ID: 25328897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone disease in thyrotoxicosis.
    Reddy PA; Harinarayan CV; Sachan A; Suresh V; Rajagopal G
    Indian J Med Res; 2012 Mar; 135(3):277-86. PubMed ID: 22561612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma.
    Reverter JL; Colomé E; Holgado S; Aguilera E; Soldevila B; Mateo L; Sanmartí A
    Endocrine; 2010 Jun; 37(3):467-72. PubMed ID: 20960170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference.
    Mohammadi B; Haghpanah V; Tavangar SM; Larijani B
    Theor Biol Med Model; 2007 Jun; 4():23. PubMed ID: 17559682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.
    Majima T; Komatsu Y; Doi K; Takagi C; Shigemoto M; Fukao A; Morimoto T; Corners J; Nakao K
    Osteoporos Int; 2006; 17(7):1103-10. PubMed ID: 16601919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of osteoporosis.
    Samelson EJ; Hannan MT
    Curr Rheumatol Rep; 2006 Feb; 8(1):76-83. PubMed ID: 16515770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid cancer: medical management and follow-up.
    Kloos RT
    Curr Treat Options Oncol; 2005 Jul; 6(4):323-38. PubMed ID: 15967085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical thyroid disorders: the menace of the Trojan horse.
    Duntas LH
    J Endocrinol Invest; 2003 May; 26(5):472-80. PubMed ID: 12906377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of thyroid hormones.
    Williams JB
    Drugs Aging; 1997 Dec; 11(6):460-9. PubMed ID: 9413703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C; Golia F; Vignali E; Pinchera A
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B; Puavilai G; Rajatanavin R
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.